Table 4.

Univariate analysis for relapse assessment at 1 year and 3 years after eltrombopag

	Hazard ratio	p	1-year expected events (SE)	3-year expected events (SE)
Age (per decade)	0.8	0.293
22-year			0.08 (0.02)	0.39 (0.04)
46-year			0.05 (0.01)	0.23 (0.06)
Sex	0.897	0.866
Male			0.06 (0.01)	0.26 (0.08)
Female			0.07 (0.02)	0.29 (0.11)
Duration of ITP (years)	0.726 (per 1 log year)	0.198
1-year			0.07 (0.007)	0.33 (0.04)
6-year			0.04 (0.01)	0.19 (0.06)
Prior therapy	0.879	0.845
≤3 prior lines of therapy			0.07 (0.02)	0.3 (0.09)
>3 prior lines of therapy			0.06 (0.02)	0.26 (0.1)
Splenectomy	1.375	0.689
Yes			0.06 (0.006)	0.27 (0.02)
No			0.08 (0.04)	0.37 (0.18)
Hemoglobin (g/dL)	1.243	0.144
11.7			0.03 (0.009)	1.77 (0.06)
14.9			0.09 (0.02)	1.42 (0.12)
WBC (/μL)	1.125 (per 1000 WBC/μL )	0.3
6700			0.05 (0.009)	0.23 (0.04)
10000			0.07 (0.009)	0.34 (0.05)
Paltelets	1.016 (per 1000 platelets/μL)	0.627
≤5000			0.05 (0.02)	0.25 (0.07)
17000			0.07 (0.01)	0.32 (0.06)